Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. pharmaceutical mixtures using field
Show results for
Products
Services
Training
Applications

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Pharmaceutical Mixtures Using Field Articles & Analysis

24 news found

Sale of 0.025-0.08mm 8011 / 8021 / 8079 O-temper Cold Forming Aluminum Foil for Pharmaceutical Packaging

Sale of 0.025-0.08mm 8011 / 8021 / 8079 O-temper Cold Forming Aluminum Foil for Pharmaceutical Packaging

What is Cold Forming Aluminum Foil? Cold forming aluminum foil is a high-barrier laminated material used in pharmaceutical packaging. It is composed of multiple layers of different films through a lamination process, with the core layer being O-temper (soft) aluminum foil. This structure provides excellent deep-drawing performance. Structure of Cold Forming Aluminum Foil A typical cold forming ...

ByHenan Hongchang Aluminum Co., Ltd.


Alfa Chemistry Expands Pharmaceutical Product Portfolio: Introducing PROTAC Building Blocks, Nucleosides, Intermediates, and APIs

Alfa Chemistry Expands Pharmaceutical Product Portfolio: Introducing PROTAC Building Blocks, Nucleosides, Intermediates, and APIs

Alfa Chemistry is one of the leading chemical manufacturers and suppliers who has been able to maintain its leadership position in the pharmaceutical sector by offering a broad product portfolio that caters to all aspects of the drug creation process. Always innovative and outstanding, Alfa Chemistry now has an extensive range of products within the pharmaceutical field, including PROTAC building ...

ByAlfa Chemistry


Protheragen-ING Announces Participation in 26th SAPA-NE Annual Conference   

Protheragen-ING Announces Participation in 26th SAPA-NE Annual Conference  

[Cambridge, June 8, 2024] Protheragen-ING is pleased to announce its participation in the 26th SAPA-NE Annual Conference. The event will be held at the Cambridge Marriott Boston (50 Broadway, Cambridge, MA 02142), on June 8, 2024, 9 am - 5 pm EDT. About SAPA-NE SAPA (Sino-American Pharmaceutical Professionals Association) is one of the most active and largest Chinese-based biopharmaceutical ...

ByProtheragen-ING


CD Formulation Develops, Evaluates, and Utilizes Innovative Drug Delivery Technologies for the Pharmaceutical Industry   

CD Formulation Develops, Evaluates, and Utilizes Innovative Drug Delivery Technologies for the Pharmaceutical Industry  

CD Formulation is making waves in the pharmaceutical industry with its innovative drug delivery technologies. With a focus on sustained and controlled release formulations, as well as liquid, semi-solid, injectable, and nanoformulations, CD Formulation is at the forefront of the industry's efforts to enhance drug efficacy. One of CD Formulation's key technology platforms is its sustained ...

ByCD Formulation


Novel Drug Delivery System Unveiled: CD Formulation Launches Oral Thin Films Technology   

Novel Drug Delivery System Unveiled: CD Formulation Launches Oral Thin Films Technology  

In a groundbreaking development in the field of pharmaceuticals, CD Formulation, a prominent drug formulation company, has announced the launch of Oral Thin Film Technology. This cutting-edge drug delivery system is poised to revolutionize medication administration, offering patients a more convenient and effective treatment method. Oral Thin Film Technology is a user-friendly drug delivery ...

ByCD Formulation


CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced an expanded portfolio of Polydimethylsiloxane (PDMS) products, empowering researchers with versatile and biocompatible tools for groundbreaking discoveries. Polydimethylsiloxane is an elastomeric polymer with interesting properties for biomedical applications, including ...

ByCD Bioparticles


Stability Analysis Plays a Crucial Role in Pharmaceutical Formulation, Highlighted by CD Formulation   

Stability Analysis Plays a Crucial Role in Pharmaceutical Formulation, Highlighted by CD Formulation  

In the field of pharmaceutical formulation, stability analysis is a critical aspect that ensures the safety and efficacy of drugs throughout their shelf life. CD formulation has introduced a series of stability analysis services as a prominent tool for researchers to understand the influence of various factors and tests on the stability of pharmaceutical products. With extensive expertise in ...

ByCD Formulation


Alfa Chemistry Leads the Way to Unleash Power of Computational Solutions in Solid State Chemistry for Pharmaceutical Research   

Alfa Chemistry Leads the Way to Unleash Power of Computational Solutions in Solid State Chemistry for Pharmaceutical Research  

In the ever-evolving field of pharmaceutical research, the hunt for effective drugs often rests on the ability to understand and manipulate the solid-state properties of compounds. Alfa Chemistry, a leading provider of research and development solutions, is taking the lead in harnessing the power of computational solutions in solid state chemistry to facilitate pharmaceutical research. ...

ByAlfa Chemistry


Amerigo Scientific Introduces Hydrazide Gel Kit for High-Yield Protein Purification

Amerigo Scientific Introduces Hydrazide Gel Kit for High-Yield Protein Purification

Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, is delighted to announce the launch of its featured product, the Hydrazide Gel Kit for high-yield protein purification. This innovative kit is set to revolutionize the field of protein purification by offering excellent performance, efficiency, and reliability. ...

ByAmerigo Scientific


Maximizing Therapeutic Potential: CD Formulation's Versatile Drug Delivery Systems Advance Pharmacokinetics and Pharmacodynamics   

Maximizing Therapeutic Potential: CD Formulation's Versatile Drug Delivery Systems Advance Pharmacokinetics and Pharmacodynamics  

In the ever-evolving field of pharmaceuticals, CD Formulation has emerged as a major player in developing innovative drug delivery systems aimed at enhancing the efficacy and safety of therapies. Through its expertise in various cutting-edge technologies such as microneedle and thin film technologies, transdermal patches, microencapsulation, and nanoparticle development, CD Formulation is ...

ByCD Formulation


CD Formulation Provides In Vitro Cytotoxicity Testing for Microspheres and Microneedles   

CD Formulation Provides In Vitro Cytotoxicity Testing for Microspheres and Microneedles  

In recent years, the field of drug delivery has witnessed great advancements in the development of microspheres and microneedles, revolutionizing the way drugs are administered. These innovative technologies offer targeted and sustained release of therapeutic agents, promoting improved patient compliance and efficacy. However, as with any medical product, it is crucial to assess the safety and ...

ByCD Formulation


CD Formulation Empowers High-volume Manufacturing of Microspheres

CD Formulation Empowers High-volume Manufacturing of Microspheres

Over the past decade, innovation in the field of microsphere production has reached new heights. Thanks to groundbreaking technology, CD Formulation has enabled mass production services for these versatile particles. Through a cutting-edge approach, CD Formulation is well-prepared to serve the industry by offering efficient and effective solutions for the mass fabrication of microspheres. From ...

ByCD Formulation


CD Formulation Newly Launches 100+ Raw Materials for Preparation of Microspheres and Microneedles

CD Formulation Newly Launches 100+ Raw Materials for Preparation of Microspheres and Microneedles

Microsphere formulation has been highlighted as a promising dosage form in clinical practice due to its ability to significantly improve patient convenience and compliance. As a trustworthy partner in the field of pharmaceutical formulation, CD Formulation has newly introduced a range of raw materials for the production of microspheres and microneedles, which are highly expected to advance ...

ByCD Formulation


CD Formulation Exhibits Proficiency in Contact Angle Determination of Pharmaceutical Excipients

CD Formulation Exhibits Proficiency in Contact Angle Determination of Pharmaceutical Excipients

Offering: l Determination of Critical Micelle Concentration and Surface Tension l Determination of the Contact Angle of a Drop of Liquid on the Surface of a Surfactant-excipient Mixture l Determination of Dynamic Contact Angle of Droplets on the Surface of Excipients Please visit the website ...

ByCD Formulation


ApiLabs, R&D sister company to ApiJect, launches its Field Research Network

ApiLabs, R&D sister company to ApiJect, launches its Field Research Network

ApiLabs, an R&D company developing innovative, affordable medical technologies to maximize healthcare access for patients in all world regions, has launched its ApiLabs Field Research Network (AFRN). AFRN gathers qualitative and quantitative data from real-world settings through ground level investigations, particularly in low- and middle-income countries. Resulting information helps ApiLabs ...

ByApiJect Systems, Corp.


Fosun Pharma and Neovii signed an agreement to exclusively sell and develop Grafalon (anti-human T cell rabbit immunoglobulin) in China

Fosun Pharma and Neovii signed an agreement to exclusively sell and develop Grafalon (anti-human T cell rabbit immunoglobulin) in China

Shanghai, China and Rapperswil, Switzerland) Shanghai Fosun Pharma (Group) Co. (“Fosun Pharma”, stock code : 600196.SH; 02196.HK) announced that Shanghai Fosun Pharmaceutical Industry Development Co., Ltd. (“Fosun Pharmaceutical Industry”), a controlled subsidiary, signed an exclusive sales agency and development agreement with Switzerland ’s Neovii Pharmaceuticals ...

ByShanghai Fosun Pharmaceutical (Group) Co. Ltd.


IN8bio Appoints Kenneth R. LaMontagne, Ph.D., to Lead Business Development

IN8bio Appoints Kenneth R. LaMontagne, Ph.D., to Lead Business Development

NEW YORK, July 12, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative gamma-delta T cell therapies utilizing its DeltEx platform, today announced an appointment to its executive team to lead the Company’s business development efforts. Kenneth R. LaMontagne, Ph.D., joins the company as Senior ...

ByIN8Bio Inc.


CytoReason and Summit Pharmaceuticals International Announce the Introduction of an AI Platform to One of Japan`s Top Pharmaceutical Companies

CytoReason and Summit Pharmaceuticals International Announce the Introduction of an AI Platform to One of Japan`s Top Pharmaceutical Companies

TOKYO and TEL AVIV, Israel, Sept. 30, 2021 /PRNewswire/ -- CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summit Pharmaceuticals International (SPI), a Japanese company providing service and products to the pharmaceutical industry (wholly-owned subsidiary of Sumitomo Corporation), today announced that CytoReason has entered the ...

ByCytoReason


CD ComputaBio Has Launched Hybrid Method for Virtual Screening Service to Assist Scientists

CD ComputaBio Has Launched Hybrid Method for Virtual Screening Service to Assist Scientists

Earlier this month, CD ComputaBio, a senior US provider of computational biology services, announced that it had expanded its service line by providing hybrid method for virtual screening service to customers around the world. Since its establishment, CD ComputaBio has been committed to providing high-quality and all-round services for scientists and researchers to help them make rapid ...

ByCD ComputaBio


New Approaches to the Old Hunt for NASH Therapies

New Approaches to the Old Hunt for NASH Therapies

Non-Alcoholic Steatohepatitis (NASH) is the most severe form of non-alcoholic fatty liver disease (NAFLD). The global prevalence of NAFLD is as high as one billion and is the most common cause of chronic liver disease, affecting between 80 and 100 million in the U.S., among whom nearly 25% progress to NASH. NASH is characterized by the presence of an abnormal accumulation of fat in the liver. As ...

ByGenuity Science

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT